L. CINV (CHEMOTHERAPY INDUCED NAUSEA AND VOMITING)
Chemotherapy-induced nausea and vomiting (CINV) remains significant cause of morbidity in oncology patients. The mechanism of delayed nausea and vomiting is incompletely understood, but may involve non-serotonergic receptors including the cannabinoid CB1 receptor, with a potential role for cannabis products in its amelioration.
Cannabinoids exert their anti-emetic properties through interactions with the centrally located CB1 receptors and 5-HT3 receptors in the dorsal vagal complex (DVC), which mediates emesis. The activation of the 5-HT1A receptor ultimately reduces the amount of serotonin released, and thus a lower potential to trigger emesis. CBD is also thought to activate the CB1 receptors in the gastrointestinal tract through their GPCR (G-protein-coupled receptor) inhibitory effect, leading to decreased gastrointestinal motility. Phyto-cannabinoids such as THC and CBD also inhibit fatty acid amide hydrolase (FAAH), leading to an increased concentration of anandamide that could exert its anti-emetic properties at a higher intensity.
M.GLAUCOMA
Cannabis has the potential of becoming a useful treatment for glaucoma, as they seem to have neuroprotective properties and effectively reduce intraocular pressure. Cannabinoid receptors are found in the trabecular meshwork, non-pigmented ciliary epithelium, and ciliary muscle of human eyes.
Research
22 suggests that
Cannabis with THC can lower IOP in 60% to 65% of both normal individuals and patients with glaucoma. Intraocular pressure (IOP) is the fluid pressure inside the eye, which is an important aspect in the evaluation of patients at risk of glaucoma.
BEST PRACTICES FOR TAKING MEDICAL CANNABIS
Medical cannabis products available in India are in capsule, oil and gummy dose form. So it can be consumed orally. Best practice of taking oil is to keep for sometimes under the tongue for a better absorption.
DOSAGE
Dosage is the vital factor to reap maximum benefits with minimal side effects of cannabis medicines. HempCann Solutions, the parent company of brand Vedi, invests a lot in researching cannabis and improving awareness around it to make it a more safe, versatile, and effective drug.
It is advisable to start with a low dose, as body’s tolerance to dose varies with person to person, and there are other factors involved too, such as the state of disease, age, etc. It is best to follow a physician’s advice to find the correct dose and treatment protocol.
SIDE EFFECTS
Cannabis medicines are likely to be safe in low doses. Some reported side effects of cannabis when used for a long duration or in higher doses include:
1. l Dry mouth
2.l Decrease in blood pressure
3.l Increased heartbeat
4.l Decreased concentration levels
5.l Drowsiness
DRUG INTERACTIONS
Cannabis medicines are likely safe and can be taken with most drugs. However, it is best to consult your doctor before starting and sharing the list of all medications to learn more about drug interactions.
Cannabis can accelerate or inhibit the effects of other drugs, especially the ones that cause drowsiness, including antidepressants, antihistamines, sedatives, seizure medicines, pain relievers, anxiety medicines, muscle relaxants, and alcohol.
WHO SHOULD AVOID USING IT?
The risk/benefit ratio of cannabis should be carefully and individually evaluated, especially for people who:
- Are under 18
- Have hypersensitivity to any cannabinoid
- Have severe cardio-pulmonary disease with hypotension/ hypertension/ syncope or tachycardia
- Have a family history of schizophrenia
- Have severe respiratory diseases such as chronic obstructive pulmonary disease (COPD)
- Women who are planning pregnancy, or are pregnant, or breastfeeding.
HOW AND WHERE TO BUY IN INDIA?
Cannabis medicines are available in India. HempCann Solutions is the leading research and manufacturing company of cannabis in India. It opened the first medical cannabis clinic in India in Koramangala, Bengaluru. Vedi Wellness Centre provides Ayurvedic doctor consultation, nutritional counseling, ayurvedic medicines, herbal supplements, and natural body care products. They are operational online, too, @www.vediherbals.com.
We use the best quality ayurvedic herbs, including cannabis leaves to make its 100% vegetarian Ayurvedic medicines. Our range of Cannabis-Infused capsules and oils are made using full-spectrum Cannabis extract infused in coldpressed virgin coconut oil (for capsules) and high grade MCT oil (for oils), the Medium Chain Triglyceride extracted from Coconut. They are 100% natural and free from chemicals, artificial flavors or sweeteners, sugar, salt, gluten, soy, pesticides, and heavy metals.
VEDI’s cannabis brands for India includes-
-
Cannaflam is a natural Cannabis medicine for chronic inflammation. Available in the form of capsules and oil. This CBD dominant formulation is efficacious in -
- bringing joint pain relief
- preventing and treating bone loss
- strengthening bones
- managing cardiovascular conditions
- alleviating bowel inflammation
- fortifying the immune system
It also serves as an excellent alternative medicine for managing IBS, psoriasis, and osteoporesis.
-
Cannapain is a wholesome cannabis leaf extract medicine that is great for pain management and improving sleep. This balanced cannabinoid formulation is idea for –
- alleviating pain that affects mobility, like neck and backache.
- palliative care in cancer patients as it helps mitigate the side effects of chemotherapy, including cancer-induced nausea and vomiting.
- relieving a variety of pain, from chronic to neuropathic and from muscular spasms to sciatica pain.
- reducing anxiety
- improving the quality of sleep, controls seizures, and improves appetite.
-
Cannaron is a promising therapeutic medicine for all neurodegenerative diseases. It helps manage age-related ailments of the brain and the nervous system. This full spectrum cannabis medicine is having a higher THC and is helpful for -
- bring relief from a wide spectrum of neuropathic conditions,
- nourish the neural network.
- treat depressions, stress, anxiety and fatigue with its uplifting effects
- It is much sought after for improving mood and quality of life
- stimulate, energize and uplift mood.
All the above 3 medicines are prescription based medicines and are available in both capsule and oil dose form.
Other than that VEDI has also some classical formulation based on cannabis:
-
Kameswar Modaka: Available in 5g sachet, helpful for increasing sexual desire, enhancing vitality and vigor.
-
Jatiphaladi Churna: Available in 3g sachet, efficacious for chronic diarrhea, cold, cough and nasal congestion.
-
Bilvadi Churna: Available in 3g sachet, an excellent remedy for IBS, abdominal discomfort, gut infection.
-
Sarpagandha ghanvati: Available in 500mg tablet dose form, useful for hypertension, and insomnia.
-
Vijayadi Vati: Available in 250mg tablet dose form, an proven medicine for menstrual pain & cramp, lower back pain.
UNDERSTANDING IMPORTANT TERMS
1. Marijuana: Pronounced as “marihuana”, it is a non-scientific slang term for cannabis, composed of the cured flowers of the female plant in the genus cannabis. The term marijuana is sometimes used interchangeably with cannabis. It is usually dried and crushed to be added to food or for smoking.
2.
Medical Marijuana or Medical Cannabis: Medical cannabis, or medical marijuana (MMJ), is cannabis prescribed by physicians for their patients to treat certain conditions or disorders. It is a plant-based medicine obtained from the Cannabis Sativa or Cannabis Indica species. It comes in various forms, such as flowers, tinctures, extracts, capsules, etc.
3.
Hash Oil: Hashish, often known as "hash", is a cannabis product composed of compressed or purified preparations of stalked resin glands called trichomes. It is said to be the most potent form of cannabis due to higher THC.
4.
Hempseed Oil: The oil is extracted from seeds of the hemp plant through cold-pressing. The seeds have a rich profile of nutrients, fatty acids, and useful bioactive compounds such as omega-6 that can also have health benefits. Hemp oil is an important ingredient in many nutritional and skincare products.
5.CBD Oil: CBD oil available in the market may be full-spectrum or may be made just with CBD isolates. CBD oils contain a higher concentration of CBD and a very low percentage of THC. You might find many CBD oils in the market which contain just the isolated CBD in them, and do not contain any other cannabinoid or terpene, hence lacking the ‘entourage effect’.
6.Cannabis Oil: Derived from cannabis leaves and/ or flowers, these oils contain a full spectrum of cannabinoids, terpenes, flavonoids and pigments, thereby providing an ‘entourage effect’. Many manufacturers and marketers label their products CBD oil instead of "cannabis oil" to attract more customers. Therefore, there is a need to ask if they are using CBD isolates or full-spectrum oil in their products and choose reliable brand like VEDI as per an individual need.
REFERENCE
- Mouhamed Y, Vishnyakov A, Qorri B, Sambi M, Frank SMS, Nowierski C, et al. . Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. Drug Healthc Patient Saf. (2018) 10:45–66. 10.2147/DHPS.S158592 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001746/
- Poli P, Crestani F, Salvadori C, Valenti I, Sannino C. Medical Cannabis in Patients with Chronic Pain: Effect on Pain Relief, Pain Disability, and Psychological aspects. A Prospective Non randomized Single Arm Clinical Trial. Clin Ter. 2018 May-Jun;169(3):e102-e107. doi: 10.7417/T.2018.2062. PMID: 29938740. https://pubmed.ncbi.nlm.nih.gov/29938740/
- Calignano, A.; la Rana, G.; Giuffrida, A.; Piomelli, D. Control of pain initiation by endogenous cannabinoids. Nature 1998, 394, 277–281
- Costa, B.; Trovato, A.E.; Comelli, F.; Giagnoni, G.; Colleoni, M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur. J. Pharmacol. 2007, 556, 75–83.
- Carolina Chaves, MD, Paulo Cesar T Bittencourt, MD, MSc, Andreia Pelegrini, PhD, Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Pain Medicine, Volume 21, Issue 10, October 2020, Pages 2212–2218, https://doi.org/10.1093/pm/pnaa303
- Mishima, K.; Hayakawa, K.; Abe, K.; Ikeda, T.; Egashira, N.; Iwasaki, K.; Fujiwara, M. Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke 2005, 36, 1077–1082
- Flachenecker P, Henze T, Zettl UK. Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity. Eur Neurol. 2014;71(5-6):271-9. doi: 10.1159/000357427. Epub 2014 Feb 12. PMID: 24525548. https://pubmed.ncbi.nlm.nih.gov/24525548/
- Childs E, Lutz JA, de Wit H. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug and Alcohol Dependence 2017;177:136-44
- Shelef, Assaf et al. ‘Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study’. 1 Jan. 2016 : 15 – 19. https://content.iospress.com/articles/journal-of-alzheimers-disease/jad150915
- Elliott, J, DeJean, D, Clifford, T, et al. Cannabis-based products for pediatric epilepsy: A systematic review. Epilepsia. 2019; 60: 6– 19. https://doi.org/10.1111/epi.14608
- Akinyemi E. et al., Medical Marijuana Effects in Movement Disorders, Focus on Huntington Disease; A Literature Review. J Pharm Pharm Sci., 23, 389 - 395, 2020.
- Society for the Study of Ingestive Behavior. (2018, July 17). How cannabis affects appetite: Brain changes. ScienceDaily. Retrieved September 13, 2021 from sciencedaily.com/releases/2018/07/180717094747.htm
- Ravikoff Allegretti J, Courtwright A, Lucci M, Korzenik JR, Levine J. Marijuana use patterns among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(13):2809-2814. doi:10.1097/01.MIB.0000435851.94391.37. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126607/
- Chagas MH, Eckeli AL, Zuardi AW, Pena-Pereira MA, Sobreira-Neto MA, Sobreira ET, Camilo MR, Bergamaschi MM, Schenck CH, Hallak JE, Tumas V, Crippa JA. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series. J Clin Pharm Ther. 2014 Oct;39(5):564-6. doi: 10.1111/jcpt.12179. Epub 2014 May 21. PMID: 24845114. https://pubmed.ncbi.nlm.nih.gov/24845114/
- Walsh SK, Hepburn CY, Kane KA, Wainwright CL. Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion. Br J Pharmacol. 2010 Jul;160(5):1234-42. doi: 10.1111/j.1476-5381.2010.00755.x. PMID: 20590615; PMCID: PMC2936031. https://pubmed.ncbi.nlm.nih.gov/20590615/
- Collin, C., Davies, P., Mutiboko, I.K., Ratcliffe, S. and (2007), Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. European Journal of Neurology, 14: 290-296. https://doi.org/10.1111/j.1468-1331.2006.01639.x
- Jadoon, K.A., Ratcliffe, S.H., Barrett, D.A., Thomas, E.L., Stott, C., Bell, J.D., O’Sullivan S.E. and Tan, G.D. 2016. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study. Diabetes Care. 39 (10), pp. 1777-1786. https://doi.org/10.2337/dc16-0650
- Wang B, Kovalchuk A, Li D, et al. In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues. Aging (Albany NY). 2020;12(22):22425-22444. doi:10.18632/aging.202225. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746344/
- Velasco, G., Sánchez, C., & Guzmán, M. (2016). Anticancer mechanisms of cannabinoids. Current oncology (Toronto, Ont.), 23(2), S23–S32. https://doi.org/10.3747/co.23.3080
- Nagina Mangal, Simon Erridge, Nagy Habib, Anguraj Sadanandam, Vikash Reebye & Mikael Hans Sodergren: Journal of Cancer Research and Clinical Oncology (2021). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310855/
- Marcu JP, Christian RT, Lau D, Zielinski AJ, Horowitz MP, Lee J, Pakdel A, Allison J, Limbad C, Moore DH, Yount GL, Desprez PY, McAllister SD. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Mol Cancer Ther. 2010;9(1):180–189. doi: 10.1158/1535-7163.MCT-09-0407. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806496/
- Poli P, Crestani F, Salvadori C, Valenti I, Sannino C. Medical Cannabis in Patients with Chronic Pain: Effect on Pain Relief, Pain Disability, and Psychological aspects. A Prospective Non randomized Single Arm Clinical Trial. Clin Ter. 2018 May-Jun;169(3):e102-e107. doi: 10.7417/T.2018.2062. PMID: 29938740. https://pubmed.ncbi.nlm.nih.gov/29938740/